Skip to content

One-month Clinical Evaluation of Silicone Hydrogel Definitive 65 HPT Contact Lenses

One-month Clinical Evaluation of Silicone Hydrogel Definitive 65 HPT Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02312323
Enrollment
35
Registered
2014-12-09
Start date
2014-11-08
Completion date
2015-05-23
Last updated
2020-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ametropia

Brief summary

Comparison of different contact lens materials.

Detailed description

This is a 1-month, open-label, bilateral, parallel-group, randomised, daily wear study. Two-thirds of the subjects will wear the Test lenses in both eyes, and one-third will wear the Control lenses in both eyes.

Interventions

DEVICEDefinitive 65 HPT contact lenses
DEVICEDefinitive 65 contact lenses

Sponsors

Hartwig Research Center
CollaboratorINDUSTRY
Contamac Ltd
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* willing and able to sign informed consent form * ages 18 years or older * Subjects must have owned spectacles or contact lenses prior to enrolment for this trial * Spherical power between -10.00 D and +10.00 D (at vertex distance 0 mm) * Astigmatic power ≤0.75 D

Exclusion criteria

* Eye injury or surgery within 3 months immediately prior to enrolment for this trial * Pre-existing ocular irritation that would preclude contact lens fitting * Currently enrolled in an ophthalmic clinical trial * Evidence of systemic or ocular abnormality, infection or disease which is likely to affect successful wear of contact lenses or use of the accessory solutions, as determined by the investigator * Any use of medications for which contact lens wear could be contradicted, as determined by the investigator * Current extended-wear users (sleep-in overnight) * Current monovision lens wearers * Pregnant women and nursing mothers * Best-corrected visual acuity worse than 6/9 (LogMAR: +0.20; Snellen decimal: 0.63)

Design outcomes

Primary

MeasureTime frameDescription
questionnaire addressing subjective comfort and wear timesubjects will be followed-up for one monthSubjects rated on a scale from 1 to 10, where 1 was 'poor' and 10 was 'excellent'.
limbal redness - ocular biomicroscopysubjects will be followed-up for one monthAssessed using slit lamp with white light, low-medium magnification. Graded based on a grading scale which ranged from 0 to 4, where 0 is none, 1 is trace, 2 is mild, 3 is moderate and 4 is severe.
conjunctival redness - ocular biomicroscopysubjects will be followed-up for one monthAssessed using slit lamp with white light, low-medium magnification. Graded based on a grading scale which ranged from 0 to 4, where 0 is none, 1 is trace, 2 is mild, 3 is moderate and 4 is severe.
corneal staining - ocular biomicroscopysubjects will be followed-up for one monthAssessed using slit lamp with white light, low-medium magnification. Graded based on a grading scale which ranged from 0 to 4, where 0 is none, 1 is trace, 2 is mild, 3 is moderate and 4 is severe.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026